Quarterly report pursuant to Section 13 or 15(d)

Discontinued Operations - Assets and liabilities reported as discontinued operations in balance sheet (Details)

v3.22.2
Discontinued Operations - Assets and liabilities reported as discontinued operations in balance sheet (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Discontinued operations - current assets $ 14 $ 12
Discontinued operations - current liabilities 1,132 1,144
U.S. commercialization activities | Discontinued operations    
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]    
Prepaid expenses and other current assets 14 12
Discontinued operations - current assets 14 12
Accounts payable 769 782
Accrued clinical trials expenses 1 0
Other accrued liabilities 362 362
Discontinued operations - current liabilities $ 1,132 $ 1,144